SKIN RSI Chart
Last 30 days
-17.2%
Last 90 days
-12.5%
Trailing 12 Months
-73.1%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 393.1M | 0 | 0 | 0 |
2023 | 376.7M | 390.7M | 399.3M | 398.0M |
2022 | 288.0M | 325.0M | 345.6M | 365.9M |
2021 | 306.5M | 358.9M | 392.5M | 260.1M |
2020 | 0 | 150.8M | 134.9M | 119.1M |
2019 | 0 | 0 | 0 | 166.6M |
Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index
Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>
Returns of $10,000 invested in:
Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224
Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Apr 09, 2024 | monahan michael p. | acquired | - | - | 292,207 | chief financial officer |
Apr 09, 2024 | beck marla malcolm | acquired | - | - | 837,662 | president and ceo |
Apr 09, 2024 | watson daniel copell | acquired | - | - | 243,506 | chief revenue oficer |
Nov 29, 2023 | hauser bradley | acquired | - | - | 176,711 | chief operating officer |
Nov 29, 2023 | watson daniel copell | acquired | - | - | 156,250 | chief revenue oficer |
Nov 29, 2023 | monahan michael p. | acquired | - | - | 176,711 | chief financial officer |
Nov 20, 2023 | beck marla malcolm | acquired | - | - | 213,675 | interim ceo |
Aug 17, 2023 | miller brian christopher | bought | 348,600 | 5.81 | 60,000 | - |
Aug 17, 2023 | capellas michael d | bought | 180,948 | 6.0316 | 30,000 | - |
Aug 17, 2023 | stanleick andrew roy | bought | 99,815 | 6.0549 | 16,485 | chief executive officer |
Which funds bought or sold SKIN recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 16, 2024 | Creekmur Asset Management LLC | sold off | -100 | -389 | - | -% |
May 16, 2024 | JANE STREET GROUP, LLC | reduced | -61.12 | -893,985 | 1,115,230 | -% |
May 16, 2024 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | reduced | -91.00 | -245,070 | 36,146 | -% |
May 15, 2024 | TWO SIGMA SECURITIES, LLC | sold off | -100 | -257,555 | - | -% |
May 15, 2024 | PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO | unchanged | - | 22,000 | 75,000 | -% |
May 15, 2024 | CITADEL ADVISORS LLC | added | 60.43 | 3,118,600 | 5,535,350 | -% |
May 15, 2024 | QUADRANT CAPITAL GROUP LLC | reduced | -74.66 | -9,385 | 5,320 | -% |
May 15, 2024 | Point72 Asset Management, L.P. | added | 66.15 | 9,726,360 | 16,815,600 | 0.04% |
May 15, 2024 | TWO SIGMA INVESTMENTS, LP | sold off | -100 | -1,100,520 | - | -% |
May 15, 2024 | JANUS HENDERSON GROUP PLC | reduced | -0.12 | 14,968,900 | 50,111,900 | 0.03% |
Unveiling The Beauty Health Company's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to The Beauty Health Company)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
PG | 395.7B | 84.1B | 26.16 | 4.71 | ||||
CL | 77.2B | 19.8B | 29.57 | 3.91 | ||||
EL | 48.4B | 15.3B | 72.94 | 3.15 | ||||
CHD | 26.0B | 5.9B | 33.35 | 4.38 | ||||
CLX | 16.8B | 7.2B | 70.19 | 2.34 | ||||
COTY | 9.2B | 6.1B | 42.16 | 1.51 | ||||
ELF | 8.8B | 890.1M | 67.98 | 9.88 | ||||
MID-CAP | ||||||||
IPAR | 4.0B | 1.3B | 28.55 | 3 | ||||
NWL | 3.4B | 8.0B | -11.41 | 0.42 | ||||
HIMS | 3.1B | 959.4M | -1.3K | 3.24 | ||||
HELE | 2.6B | 2.0B | 15.38 | 1.29 | ||||
SMALL-CAP | ||||||||
EPC | 2.0B | 2.3B | 16.18 | 0.88 | ||||
ACU | 144.4M | 190.6M | 7.83 | 0.76 | ||||
GROV | 55.5M | 241.3M | -1.65 | 0.23 | ||||
UG | 42.3M | 11.6M | 15.37 | 3.65 |
The Beauty Health Company News
Income Statement (Quarterly) | ||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2019Q4 |
Revenue | -15.9% | 81,403,000 | 96,821,000 | 97,413,000 | 117,479,000 | 86,278,000 | 98,133,000 | 88,792,000 | 103,536,000 | 75,415,000 | 77,889,000 | 68,147,000 | 66,508,000 | 47,542,000 | 210,308,968 | 34,560,000 | 14,116,000 | - |
Cost Of Revenue | -35.4% | 33,042,000 | 51,135,000 | 109,966,000 | 49,603,000 | 32,174,000 | 31,642,000 | 27,429,000 | 33,496,000 | 24,530,000 | 24,417,000 | 22,072,000 | 19,257,000 | 15,802,000 | 14,843,000 | 13,603,000 | 9,840,000 | - |
Gross Profit | 5.9% | 48,361,000 | 45,686,000 | -12,553,000 | 67,876,000 | 54,104,000 | 66,491,000 | 61,363,000 | 70,040,000 | 50,885,000 | 53,472,000 | 46,075,000 | 47,251,000 | 31,740,000 | 23,037,000 | 20,957,000 | 4,276,000 | - |
Operating Expenses | 2.0% | 65,352,000 | 64,046,000 | 69,548,000 | 81,022,000 | 71,414,000 | 68,939,000 | 65,716,000 | 75,067,000 | 64,898,000 | 63,973,000 | 51,531,000 | 73,604,000 | 29,358,000 | 27,748,000 | 18,172,000 | 12,195,000 | - |
S&GA Expenses | 5.2% | 33,684,000 | 32,025,000 | 30,731,000 | 43,041,000 | 38,699,000 | 39,021,000 | 39,767,000 | 44,881,000 | 36,407,000 | 37,438,000 | 30,451,000 | 26,214,000 | 17,095,000 | 15,898,500 | 10,541,000 | 6,186,000 | - |
R&D Expenses | -7.8% | 2,807,000 | 3,046,000 | 1,839,000 | 2,881,000 | 2,336,000 | 1,446,000 | 2,167,000 | 2,601,000 | 2,230,000 | 1,875,000 | 1,880,000 | 2,988,000 | 1,452,000 | 859,500 | 577,000 | 597,000 | - |
EBITDA Margin | 30.2% | -0.14 | -0.20 | -0.17 | 0.01 | 0.02 | 0.18 | 0.11 | -0.56 | -1.13 | -1.40 | -0.90 | -0.39 | - | - | - | - | - |
Interest Expenses | -9.8% | 3,029,000 | 3,358,000 | 3,445,000 | 3,429,000 | 3,417,000 | 3,395,000 | 3,380,000 | 3,217,000 | 3,400,000 | 1,528,000 | - | 7,126,000 | 3,123,000 | 3,104,000 | 3,171,000 | 3,111,000 | - |
Income Taxes | -216.1% | -700,000 | 603,000 | 3,479,000 | -2,193,000 | -3,662,000 | -780,500 | -800,000 | 76,000 | 2,615,000 | 1,427,500 | -1,100,000 | -1,900,000 | -300,000 | -3,048,500 | -593,000 | -3,052,000 | - |
Earnings Before Taxes | 82.8% | -1,338,000 | -7,787,000 | -70,339,000 | 1,171,000 | -25,947,000 | 5,778,000 | -902,000 | 6,393,000 | 34,070,000 | -19,537,000 | -216,274,000 | -141,248,000 | -3,580,000 | -10,542,000 | -2,807,000 | -13,449,000 | - |
EBT Margin | 23.0% | -0.20 | -0.26 | -0.22 | -0.05 | -0.04 | 0.12 | 0.06 | -0.60 | -1.19 | -1.46 | -0.95 | -0.44 | - | - | - | - | - |
Net Income | 92.8% | -679,000 | -9,403,000 | -73,818,000 | 3,364,000 | -20,259,000 | 6,533,000 | -81,000 | 6,317,000 | 31,455,000 | -20,967,000 | -215,145,000 | -139,378,000 | -3,274,000 | -7,494,000 | -2,214,000 | -10,397,000 | - |
Net Income Margin | 18.6% | -0.20 | -0.25 | -0.21 | -0.03 | -0.02 | 0.12 | 0.05 | -0.61 | -1.19 | -1.46 | -0.93 | -0.42 | - | - | - | - | - |
Free Cashflow | -230.9% | -17,198,000 | -5,198,000 | 17,790,000 | 20,662,000 | -15,329,000 | -6,360,000 | -35,704,000 | -33,763,000 | -41,620,000 | -3,065,000 | 148,000 | -37,088,000 | - | - | - | - | - |
Balance Sheet | |||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2019Q4 |
Assets | -9.1% | 845 | 929 | 973 | 1,007 | 995 | 1,003 | 1,105 | 1,215 | 1,199 | 1,219 | 998 | 343 | 464 | 223 | 225 | 226 |
Current Assets | -11.9% | 615 | 698 | 738 | 768 | 749 | 783 | 892 | 996 | 982 | 1,001 | 798 | 174 | 3.00 | 59.00 | - | 54.00 |
Cash Equivalents | -15.0% | 445 | 523 | 559 | 550 | 532 | 568 | 684 | 821 | 859 | 902 | 719 | 101 | 14.00 | 9.00 | 12.00 | 7.00 |
Inventory | 4.8% | 96.00 | 91.00 | 75.00 | 107 | 122 | 110 | 102 | 74.00 | 47.00 | 35.00 | 28.00 | 24.00 | 22.00 | 23.00 | - | 19.00 |
Net PPE | - | - | - | - | - | - | - | - | - | - | - | 12.00 | 10.00 | 8.00 | 9.00 | - | 11.00 |
Goodwill | -0.4% | 125 | 126 | 125 | 125 | 125 | 125 | 123 | 4.00 | 124 | 124 | 123 | 103 | 99.00 | 99.00 | 99.00 | 99.00 |
Liabilities | -10.2% | 781 | 870 | 883 | 846 | 847 | 836 | 847 | 863 | 857 | 917 | 1,140 | 326 | 68.00 | 253 | - | 228 |
Current Liabilities | -18.6% | 94.00 | 115 | 126 | 83.00 | 72.00 | 72.00 | 76.00 | 87.00 | 69.00 | 76.00 | 49.00 | 39.00 | 1.00 | 31.00 | 0.00 | 38.00 |
Long Term Debt | -9.9% | 665 | 738 | 737 | 736 | 735 | 734 | 733 | 732 | 731 | 730 | 729 | - | 218 | - | - | 181 |
LT Debt, Non Current | -100.0% | - | 738 | 737 | 736 | 735 | 734 | 733 | 732 | 731 | 730 | 729 | - | 218 | - | - | 181 |
Shareholder's Equity | 6.6% | 63.00 | 59.00 | 90.00 | 162 | 152 | 167 | 251 | 345 | 336 | 298 | - | 16.00 | - | 5.00 | 0.00 | - |
Retained Earnings | -0.1% | -479 | -478 | -469 | -395 | 5.00 | -378 | -378 | -378 | -386 | -418 | -401 | -186 | -68.02 | -43.60 | 0.00 | -14.43 |
Additional Paid-In Capital | 1.0% | 547 | 541 | 565 | 561 | 555 | 550 | 643 | 736 | 729 | 722 | 261 | 202 | 3.00 | 14.00 | 0.00 | 14.00 |
Shares Outstanding | 0.5% | 123 | 123 | 133 | 133 | 133 | 132 | 151 | 151 | 151 | 102 | 132 | 64.00 | - | - | - | - |
Float | - | - | - | - | 729 | - | - | - | 1,340 | - | - | - | 1,410 | - | 558 | - | - |
Cashflow (Quarterly) | ||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2018Q4 |
Cashflow From Operations | -226.0% | -16,854 | -5,170 | 17,964 | 21,966 | -13,010 | -5,393 | -31,401 | -31,335 | -38,471 | 3,279 | 298 | -33,199 | 1,261 | -752 | -540* | -6,579 | -5,054 | - | - |
Share Based Compensation | 193.9% | 6,636 | 2,258 | 8,185 | 8,524 | 3,577 | 7,619 | 7,449 | 6,378 | 7,049 | 3,794 | 5,082 | 3,508 | 34.00 | 37.00 | 76.00 | 224 | 26.00 | - | - |
Cashflow From Investing | 16.9% | -1,802 | -2,168 | -4,436 | -3,219 | -21,684 | -2,824 | -7,741 | -4,879 | -3,425 | -8,530 | -20,082 | -8,131 | -988 | -1,120 | -1,272 | 818 | -2,243 | - | - |
Cashflow From Financing | -86.9% | -58,618 | -31,357 | -2,350 | -1,546 | -2,195 | -102,479 | -100,000 | -1,980 | -783 | 188,210 | 637,776 | 128,672 | 4,377 | 231,707 | 26.00 | 14,480 | 6,057 | - | - |
Buy Backs | -100.0% | - | 30,155 | 4,828 | - | - | 80,000 | 80,000 | - | - | - | - | - | - | - | - | - | - | - | - |
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($) $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Income Statement [Abstract] | ||
Net sales | $ 81,403 | $ 86,278 |
Cost of sales | 33,042 | 32,174 |
Gross profit | 48,361 | 54,104 |
Operating expenses: | ||
Selling and marketing | 33,684 | 38,699 |
Research and development | 2,807 | 2,336 |
General and administrative | 28,861 | 30,379 |
Total operating expenses | 65,352 | 71,414 |
Loss from operations | (16,991) | (17,310) |
Interest expense | 3,029 | 3,417 |
Interest income | (5,356) | (4,315) |
Other income, net | (16,087) | (418) |
Change in fair value of warrant liabilities | 1,464 | 9,076 |
Foreign currency transaction loss (gain), net | 1,297 | (1,149) |
Loss before provision for income taxes | (1,338) | (23,921) |
Income tax benefit | (659) | (3,662) |
Net loss | (679) | (20,259) |
Comprehensive loss, net of tax: | ||
Foreign currency translation adjustments | (1,047) | 888 |
Comprehensive loss | $ (1,726) | $ (19,371) |
Net loss per share | ||
Basic (in dollars per share) | $ (0.01) | $ (0.15) |
Diluted (in dollars per share) | $ (0.10) | $ (0.15) |
Weighted average common shares outstanding | ||
Basic (in shares) | 123,120,426 | 132,420,762 |
Diluted (in shares) | 144,477,208 | 132,420,762 |
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets: | ||
Cash, cash equivalents, and restricted cash | $ 444,634 | $ 523,025 |
Accounts receivable, net of allowances for estimated credit losses of $7,228 and $6,604 at March 31, 2024 and December 31, 2023, respectively | 47,666 | 54,697 |
Inventories | 95,721 | 91,321 |
Income tax receivable | 1,204 | 332 |
Prepaid expenses and other current assets | 25,599 | 28,877 |
Total current assets | 614,824 | 698,252 |
Property and equipment, net | 12,048 | 14,226 |
Right-of-use assets, net | 16,383 | 12,120 |
Intangible assets, net | 58,405 | 62,123 |
Goodwill | 125,365 | 125,818 |
Deferred income tax assets, net | 1,932 | 531 |
Other assets | 15,784 | 16,043 |
TOTAL ASSETS | 844,741 | 929,113 |
Current liabilities: | ||
Accounts payable | 37,312 | 44,768 |
Accrued payroll-related expenses | 15,456 | 22,028 |
Syndeo Program reserves | 8,314 | 21,009 |
Lease liabilities, current | 4,648 | 4,598 |
Income tax payable | 3,443 | 2,759 |
Other accrued expenses | 24,395 | 19,846 |
Total current liabilities | 93,568 | 115,008 |
Lease liabilities, non-current | 13,688 | 9,319 |
Deferred income tax liabilities, net | 1,068 | 702 |
Warrant liabilities | 5,019 | 3,555 |
Convertible senior notes, net | 665,486 | 738,372 |
Other long-term liabilities | 2,617 | 2,767 |
Total liabilities | 781,446 | 869,723 |
Commitments (Note 10) | ||
Stockholders’ equity: | ||
Class A Common Stock, $0.0001 par value; 320,000,000 shares authorized; 123,453,419 and 122,899,002 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively | 12 | 12 |
Additional paid-in capital | 546,912 | 541,281 |
Accumulated other comprehensive loss | (4,083) | (3,036) |
Accumulated deficit | (479,546) | (478,867) |
Total stockholders’ equity | 63,295 | 59,390 |
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | $ 844,741 | $ 929,113 |
Mr. Andrew Stanleick | |
beautyhealth.com | |
Household Products | |
1034 |